Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2023-05-31 09:14:00
OSLO, 31st May 2023: The Annual General Meeting of EXACT Therapeutics AS
("EXACT-Tx", Euronext Growth: EXTX), will be held as a virtual meeting at 10:30
CEST on 9th June 2023.
The notice of the Annual General Meeting with Attendance/Proxy forms, including
the Board of Directors' proposed resolutions for the items listed on the agenda.
The documents are also available at www.exact-tx.com. The deadline for receiving
proxies or attendance registration is 7th June 2023 at 12:00 CEST.
For more information, please contact:
Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com
John M. Edminson, CFO
EXACT Therapeutics
Email: john.edminson@exact-tx.com
About EXACT-Tx
EXACT-Tx is a Norwegian clinical-stage precision health company developing a
technology platform for targeted therapeutic enhancement - Acoustic Cluster
Therapy (ACT®). ACT® is a proprietary formulation of microclusters (PS101)
activated by ultrasound for enhanced drug targeting deployed in multiple
indications to enhance the therapeutic efficacy of medicines through the use of
ultrasound-mediated drug delivery, for patients across multiple diseases.
www.exact-tx.com